课题基金 / 基金详情

Determination of the Molecular Basis of Biological Recognition at Functionalized Interfaces

Determination of the Molecular Basis of Biological Recognition at Functionalized Interfaces
功能化界面生物识别的分子基础的确定
批准号:
9310014
负责人:
Deborah Leckband
金额:
$10.49万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-06-15 至 1996-05-31

项目摘要

项目成果

Deborah Leckband的其他基金

相似基金

相关文献

中文摘要
翻译
通过这个项目, 支撑分子影响 受体结合表面 速率和结合亲和力 固定化配体将被 阐明。 动力学模型 受体结合有待开发 其中包含分子 互动的细节。 的 动力学和平衡结合 功能化表面的受体 将研究:(1)瞬逝 光纤荧光 光谱学;(2)定量 荧光显微镜;和(3) 放射性标记 受体吸附 解吸率和结合 亲和力将由 渐逝光纤光谱学 特异性受体的均一性 将通过以下方式评估约束力: 荧光显微镜 结合 对两种官能化的 平坦的表面和囊泡将 用放射性标记的 proteins.
英文摘要
With this project, the precise molecular influences of supporting surfaces on receptor association rates and binding affinities to immobilized ligands are to be elucidated. Kinetic models of receptor binding are to be developed which incorporate the molecular details of interactions. The kinetics and equilibrium binding of receptors to functionalized surfaces will be studied by: (1) evanescent fiber optic fluorescence spectroscopy; (2) quantitative fluorescence microscopy; and (3) radiolabelling. Receptor adsoption and desorption rates and binding affinities will be determined by evanescent fiber optic spectroscopy. The uniformity of specific receptor binding will be assessed by fluorescence microscopy. Binding affinities to both functionalized planar surfaces and vesicles will be determined with radiolabelled proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tuning intercellular cues to regulate paracrine secretion for enhanced neovascularization
Biomedical Engineering Society (BMES) 2019 Cellular and Molecular Bioengineering (CMBE) Conference
Mechanotransduction from Cells to Tissues: Mechanisms and Physiological Significance
Microenvironments Fit for Proteins
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant